Patterns of patient discontinuation from buprenorphine/naloxone treatment for opioid use disorder: A study of a commercially insured population in Massachusetts

Research has shown buprenorphine/naloxone to be an effective medication for treating individuals with opioid use disorder. At the same time, treatment discontinuation rates are reportedly high though but much of the extant evidence comes from studies of the Medicaid population.

Source: Journal of Substance Abuse Treatment - April 19, 2021 Category: Addiction Authors: Mahmudul Hasan, Noor-E-Alam, Prathamesh Mohite, Saiful Islam, Alicia Sasser Modestino, Alyssa M. Peckham, Leonard D. Young, Gary J. Young Source Type: research